mitomycin has been researched along with Carcinoma, Colloid in 53 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study evaluated health-related quality of life (HRQOL) using patient-reported outcomes in subjects with mucinous appendiceal neoplasms who underwent cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as part of a randomized trial comparing mitomycin with oxaliplatin." | 9.34 | Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin. ( Bartlett, DL; Levine, EA; Mansfield, P; McQuellon, R; Moaven, O; Russell, G; Shen, P; Stewart, JH; Votanopoulos, KI, 2020) |
| "Oxaliplatin and Mitomycin C (MMC) are both suitable as intraperitoneal chemotherapy agents in HIPEC for peritoneal carcinomatosis (PC) of colorectal cancer (CRC)." | 7.80 | The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study. ( Bruin, S; D'Hoore, A; Fieuws, S; Hompes, D; Mirck, B; Verwaal, V; Wolthuis, A, 2014) |
| "This study evaluated health-related quality of life (HRQOL) using patient-reported outcomes in subjects with mucinous appendiceal neoplasms who underwent cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as part of a randomized trial comparing mitomycin with oxaliplatin." | 5.34 | Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin. ( Bartlett, DL; Levine, EA; Mansfield, P; McQuellon, R; Moaven, O; Russell, G; Shen, P; Stewart, JH; Votanopoulos, KI, 2020) |
| "Oxaliplatin and Mitomycin C (MMC) are both suitable as intraperitoneal chemotherapy agents in HIPEC for peritoneal carcinomatosis (PC) of colorectal cancer (CRC)." | 3.80 | The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study. ( Bruin, S; D'Hoore, A; Fieuws, S; Hompes, D; Mirck, B; Verwaal, V; Wolthuis, A, 2014) |
| "There were 51 patients with colorectal cancer and 130 patients with appendiceal cancer." | 2.68 | Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. ( Jablonski, KA; Sugarbaker, PH, 1995) |
| "We studied how gastric cancer tissues and cells changed as a result of preoperative chemotherapy." | 2.68 | [Influence of preoperative on gastric cancer tissues and cells]. ( Chen, Z; Li, G; Liu, F, 1997) |
| "140 patients with advanced gastric cancer confirmed by pathology were treated by UFT (Uracil, FT-207) and mitomycin C (MMC) from Sept." | 2.66 | [Combined UFTM for 140 patients with advanced gastric cancer]. ( Jin, ML, 1989) |
| "Pseudomyxoma peritonei is rare, almost always of appendiceal origin, and presents in various ways relevant to abdominal surgeons." | 1.56 | Mode of Presentation in 1070 Patients With Perforated Epithelial Appendiceal Tumors, Predominantly with Pseudomyxoma Peritonei. ( Cecil, TD; Chandrakumaran, K; Dayal, S; Mohamed, F; Moran, BJ; Shariff, US, 2020) |
| "Pseudomyxoma peritonei is a disease that results from a perforated mucinous neoplasm of the appendix so that mucinous ascites and mucin-producing tumor cells are widely disseminated in a characteristic pattern throughout the abdomen and pelvis." | 1.46 | Management of an inguinal hernia in patients with pseudomyxoma peritonei. ( Sugarbaker, PH, 2017) |
| "Most classifications of mucinous appendiceal neoplasms (MAN) do not take into consideration the type of primary tumor or the burden of peritoneal disease." | 1.40 | Evaluation of a new staging classification and a Peritoneal Surface Disease Severity Score (PSDSS) in 229 patients with mucinous appendiceal neoplasms with or without peritoneal dissemination. ( Esquivel, J; Garcia, SS; Hicken, W; Seibel, J; Shekitka, K; Trout, R, 2014) |
| "Fresh samples of gastric cancer obtained from operation room were prepared to single-cell suspension (3 x 10(5) to 5 x 10(5) cells ml(-1)) and were separately exposed to taxol (TAX), cisplatin (CDDP), 5-fluorouracil (5-Fu), adriamycin (ADM), mitomycin (MMC) for 48 hours." | 1.34 | [Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA]. ( Cao, YC; Fu, ZJ; Geng, M; Tai, YH; Wang, XY; Yin, YC, 2007) |
| "Forty-eight patients with peritoneal surface malignancy were treated with hyperthermic intraperitoneal mitomycin C chemotherapy after a complete cytoreduction to remove all visible evidence of mucinous tumor." | 1.33 | Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C. ( Carmignani, CP; Stuart, OA; Sugarbaker, PH, 2006) |
| "To prepare a new dosage formulation of activated carbon nanoparticles adsorbing mitomycin C (MMC-ACNP) and evaluate the beneficial effects of intraperitoneally applied MMC-ACNP as a drug delivery system for lymphatic targeting in preventing metastasis and recurrence of gastric cancer." | 1.33 | [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma]. ( Qu, QL; Sun, L; Yang, LZ; Zhang, YG, 2006) |
| "Prognosis was poorer for patients with colon cancer, who had a median survival of 7." | 1.32 | Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy for the surgical palliation of mucinous peritoneal carcinomatosis from non-gynecologic cancer. ( Karakozis, S; Stamou, KM; Sugarbaker, PH, 2003) |
| "The outcome of patients with mucinous appendiceal neoplasms with peritoneal surface dissemination has changed as a result of a better understanding of the clinical and pathologic features of this disease." | 1.31 | Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients. ( Esquivel, J; Sugarbaker, PH, 2001) |
| "In early gastric cancer and Stage I disease, the mean values of chemotaxis and CL were elevated in comparison to controls." | 1.27 | Changes in polymorphonuclear leukocyte motility under agarose and luminol-dependent chemiluminescence response in patients with gastric cancer. ( Hirano, T, 1984) |
| "Pseudomyxoma peritonei is an unusual malignancy arising from the goblet cells of the large bowel or appendix." | 1.27 | Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment. ( Kern, K; Lack, E; Sugarbaker, PH, 1987) |
| "The chemosensitivity of human colorectal cancer was studied in relation to the biological features of the tumor using a human tumor/nude mouse in-vivo system." | 1.27 | Biological features and chemosensitivity of human colorectal cancer xenografted in nude mice. ( Yamada, K, 1987) |
| "For the response of advanced gastric cancer to chemotherapy in the National Cancer Center Hospital, the combined use of UFT and Mitomycin C gave the highest rate, 46%." | 1.27 | Radiation therapy for advanced gastric cancer. ( Akine, Y; Egawa, S; Hijikata, J; Kajiura, Y; Kitagawa, T; Ogino, T; Tsukiyama, I; Yamashita, K, 1988) |
| "She died from general metastasis seven months after the radical mastectomy in spite of adjuvant immunochemotherapy." | 1.27 | [A case of bilateral metastatic breast carcinoma from gastric carcinoma]. ( Hanamura, N; Iida, F; Kasuga, Y; Katsuyama, T; Oota, H; Senga, O; Tsuchiya, S, 1986) |
| "Mitomycin-C (MMC) is an alkylating agent which has shown significant activity in gynecologic cancers, both in vivo and in vitro." | 1.27 | Pharmacokinetics of mitomycin-C in plasma and tumor tissue of cervical cancer patients and in selected tissues of female rats. ( Boike, G; Deppe, G; Gove, N; Malviya, VK; Young, JD, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (24.53) | 18.7374 |
| 1990's | 7 (13.21) | 18.2507 |
| 2000's | 20 (37.74) | 29.6817 |
| 2010's | 10 (18.87) | 24.3611 |
| 2020's | 3 (5.66) | 2.80 |
| Authors | Studies |
|---|---|
| Moaven, O | 1 |
| Votanopoulos, KI | 1 |
| Shen, P | 1 |
| Mansfield, P | 1 |
| Bartlett, DL | 2 |
| Russell, G | 1 |
| McQuellon, R | 1 |
| Stewart, JH | 1 |
| Levine, EA | 1 |
| Bakkers, C | 1 |
| van Erning, FN | 1 |
| Rovers, KP | 1 |
| Nienhuijs, SW | 1 |
| Burger, JW | 1 |
| Lemmens, VE | 1 |
| Aalbers, AG | 1 |
| Kok, NF | 1 |
| Boerma, D | 1 |
| Brandt, AR | 1 |
| Hemmer, PH | 1 |
| van Grevenstein, WM | 1 |
| de Reuver, PR | 1 |
| Tanis, PJ | 1 |
| Tuynman, JB | 1 |
| de Hingh, IH | 1 |
| Shariff, US | 1 |
| Chandrakumaran, K | 2 |
| Dayal, S | 1 |
| Mohamed, F | 4 |
| Cecil, TD | 2 |
| Moran, BJ | 2 |
| Wang, L | 1 |
| Li, PF | 1 |
| Geng, M | 2 |
| Cao, YC | 2 |
| Yin, YC | 2 |
| Fish, R | 1 |
| Selvasekar, C | 1 |
| Crichton, P | 1 |
| Wilson, M | 1 |
| Fulford, P | 1 |
| Renehan, A | 1 |
| O'Dwyer, S | 1 |
| Hompes, D | 1 |
| D'Hoore, A | 1 |
| Wolthuis, A | 1 |
| Fieuws, S | 1 |
| Mirck, B | 1 |
| Bruin, S | 1 |
| Verwaal, V | 1 |
| Esquivel, J | 3 |
| Garcia, SS | 1 |
| Hicken, W | 1 |
| Seibel, J | 1 |
| Shekitka, K | 1 |
| Trout, R | 1 |
| Lord, AC | 1 |
| Shihab, O | 1 |
| Liu, Y | 1 |
| Ishibashi, H | 1 |
| Hirano, M | 1 |
| Takeshita, K | 1 |
| Mizumoto, A | 1 |
| Ichinose, M | 1 |
| Nishino, E | 1 |
| Kashu, I | 1 |
| Yamamoto, Y | 1 |
| Sugarbaker, PH | 13 |
| Yonemura, Y | 2 |
| Sparks, DS | 1 |
| Morris, B | 1 |
| Xu, W | 1 |
| Fulton, J | 1 |
| Atkinson, V | 1 |
| Meade, B | 1 |
| Lutton, N | 1 |
| Farquharson, AL | 1 |
| Pranesh, N | 1 |
| Witham, G | 1 |
| Swindell, R | 1 |
| Taylor, MB | 1 |
| Renehan, AG | 1 |
| Rout, S | 1 |
| Wilson, MS | 1 |
| O'Dwyer, ST | 1 |
| Saunders, MP | 1 |
| Sideris, L | 1 |
| Mitchell, A | 1 |
| Drolet, P | 1 |
| Leblanc, G | 1 |
| Leclerc, YE | 1 |
| Dubé, P | 1 |
| Yang, XJ | 1 |
| Huang, CQ | 1 |
| Suo, T | 1 |
| Mei, LJ | 1 |
| Yang, GL | 1 |
| Cheng, FL | 1 |
| Zhou, YF | 1 |
| Xiong, B | 1 |
| Li, Y | 1 |
| Austin, F | 1 |
| Mavanur, A | 1 |
| Sathaiah, M | 1 |
| Steel, J | 1 |
| Lenzner, D | 1 |
| Ramalingam, L | 1 |
| Holtzman, M | 1 |
| Ahrendt, S | 1 |
| Pingpank, J | 1 |
| Zeh, HJ | 1 |
| Choudry, HA | 1 |
| Chang, D | 2 |
| de Lima Vazquez, V | 1 |
| Stuart, OA | 2 |
| Stamou, KM | 1 |
| Karakozis, S | 1 |
| Mizuta, Y | 1 |
| Akazawa, Y | 1 |
| Shiozawa, K | 1 |
| Ohara, H | 1 |
| Ohba, K | 1 |
| Ohnita, K | 1 |
| Isomoto, H | 1 |
| Takeshima, F | 1 |
| Omagari, K | 1 |
| Tanaka, K | 1 |
| Yasutake, T | 1 |
| Nakagoe, T | 1 |
| Shirono, K | 1 |
| Kohno, S | 1 |
| Carmignani, CP | 1 |
| Smeenk, RM | 1 |
| Verwaal, VJ | 1 |
| Zoetmulder, FA | 1 |
| Alderman, R | 1 |
| Edwards, G | 1 |
| Marquardt, CE | 1 |
| Gushchin, V | 1 |
| Yan, TD | 3 |
| Links, M | 2 |
| Xu, ZY | 1 |
| Kam, PC | 2 |
| Glenn, D | 2 |
| Morris, DL | 2 |
| Qu, QL | 1 |
| Zhang, YG | 1 |
| Yang, LZ | 1 |
| Sun, L | 1 |
| Chu, F | 1 |
| Bijelic, L | 1 |
| Baratti, D | 1 |
| Kusamura, S | 1 |
| Nonaka, D | 1 |
| Langer, M | 1 |
| Andreola, S | 1 |
| Favaro, M | 1 |
| Gavazzi, C | 1 |
| Laterza, B | 1 |
| Deraco, M | 1 |
| Fu, ZJ | 1 |
| Wang, XY | 1 |
| Tai, YH | 1 |
| Hirano, T | 1 |
| Willie, GR | 1 |
| Levy, SM | 1 |
| Michaels, RS | 1 |
| Zirkin, RM | 1 |
| Jablonski, KA | 1 |
| Shimizu, Y | 2 |
| Umezawa, S | 1 |
| Hasumi, K | 1 |
| Li, G | 1 |
| Liu, F | 1 |
| Chen, Z | 1 |
| Yan, H | 1 |
| Pestieau, SR | 1 |
| Shmookler, BM | 1 |
| Michiwa, Y | 1 |
| Earashi, M | 1 |
| Kobayashi, H | 1 |
| Matsuki, N | 1 |
| Marchettini, P | 1 |
| Fujimoto, T | 1 |
| Zhang, B | 1 |
| Minami, S | 1 |
| Wang, X | 1 |
| Takahashi, Y | 1 |
| Mai, M | 1 |
| Nakamura, K | 1 |
| Hihara, T | 1 |
| Nishiumi, T | 1 |
| Yoneyama, T | 1 |
| Kirita, T | 1 |
| Ohchi, T | 1 |
| Ihara, H | 1 |
| Nishiyama, T | 1 |
| Kon, M | 1 |
| Imai, S | 1 |
| Hamano, K | 1 |
| Benedetti Panici, P | 1 |
| Scambia, G | 1 |
| Greggi, S | 1 |
| Salerno, G | 1 |
| Cento, R | 1 |
| Mancuso, S | 1 |
| Jin, ML | 1 |
| Li, XT | 1 |
| Kern, K | 1 |
| Lack, E | 1 |
| Yamada, K | 2 |
| Horiguchi, M | 1 |
| Saito, A | 1 |
| Sonoda, H | 1 |
| Tsukiyama, I | 1 |
| Akine, Y | 1 |
| Kajiura, Y | 1 |
| Ogino, T | 1 |
| Yamashita, K | 1 |
| Egawa, S | 1 |
| Hijikata, J | 1 |
| Kitagawa, T | 1 |
| Pan, XY | 1 |
| Li, FQ | 1 |
| Yu, RJ | 1 |
| Xie, GF | 1 |
| Wang, H | 1 |
| Zhao, LY | 1 |
| Zhang, Q | 1 |
| Kasuga, Y | 1 |
| Senga, O | 1 |
| Hanamura, N | 1 |
| Iida, F | 1 |
| Oota, H | 1 |
| Katsuyama, T | 1 |
| Tsuchiya, S | 1 |
| Malviya, VK | 1 |
| Young, JD | 1 |
| Boike, G | 1 |
| Gove, N | 1 |
| Deppe, G | 1 |
| Takao, S | 1 |
| Ishizawa, T | 1 |
| Shimazu, H | 1 |
| Maehara, Y | 1 |
| Anai, H | 1 |
| Kusumoto, H | 1 |
| Sugimachi, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Perioperative Systemic Therapy and Cytoreductive Surgery With HIPEC Versus Upfront Cytoreductive Surgery With HIPEC Alone for Isolated Resectable Colorectal Peritoneal Metastases: a Multicentre, Open-label, Parallel-group, Phase II-III, Randomised Superio[NCT02758951] | Phase 2/Phase 3 | 358 participants (Anticipated) | Interventional | 2017-06-01 | Recruiting | ||
| A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined With Sintilimab in Gastric Cancer With Peritoneal Metastasis[NCT05648487] | Phase 2 | 46 participants (Anticipated) | Interventional | 2023-01-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for mitomycin and Carcinoma, Colloid
| Article | Year |
|---|---|
Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; | 2005 |
Individualized chemotherapeutic regimen for each histological subtype of ovarian carcinoma.
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; C | 1997 |
Mucinous adenocarcinoma of the small bowel with peritoneal seeding.
Topics: Adenocarcinoma, Mucinous; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2002 |
10 trials available for mitomycin and Carcinoma, Colloid
| Article | Year |
|---|---|
Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Appendiceal Neoplas | 2020 |
Risk-reducing laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasm: early outcomes and technique.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Appendiceal Neoplasms; Combined Modality Therapy; Drug Admini | 2014 |
A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antige | 2008 |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 2011 |
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
Topics: Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplas | 2006 |
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antibiotics, Antineoplastic; Antineoplastic Combined Chemo | 2006 |
Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Appendicea | 1995 |
A phase II study of combined CPT-11 and mitomycin-C in platinum refractory clear cell and mucinous ovarian carcinoma.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Antineoplastic Agents, Phytogenic; Antineoplas | 1998 |
[Influence of preoperative on gastric cancer tissues and cells].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 1997 |
[Combined UFTM for 140 patients with advanced gastric cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Ch | 1989 |
40 other studies available for mitomycin and Carcinoma, Colloid
| Article | Year |
|---|---|
Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: A nationwide comparative study.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antineoplastic Agents; Colorectal Neoplasms; Cytored | 2020 |
Mode of Presentation in 1070 Patients With Perforated Epithelial Appendiceal Tumors, Predominantly with Pseudomyxoma Peritonei.
Topics: Adenocarcinoma, Mucinous; Aged; Antibiotics, Antineoplastic; Appendiceal Neoplasms; Appendicitis; Bi | 2020 |
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Agents; Biomarke | 2013 |
The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Agents; Blood Loss, Surgical; Chemotherapy, Ca | 2014 |
Evaluation of a new staging classification and a Peritoneal Surface Disease Severity Score (PSDSS) in 229 patients with mucinous appendiceal neoplasms with or without peritoneal dissemination.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Alkylating Agents; Appendectomy; Appendiceal Neoplasms; Chemo | 2014 |
Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Appendiceal Neoplas | 2015 |
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CDX2 Transcri | 2015 |
Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antibiotics, Antineoplastic; Appendiceal Neoplasms; Chemother | 2015 |
Management of an inguinal hernia in patients with pseudomyxoma peritonei.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal N | 2017 |
Surgical cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from the appendix.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Agents; Appendiceal Neoplasms; Camptothecin; C | 2009 |
Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms.
Topics: Adenocarcinoma, Mucinous; Antibiotics, Antineoplastic; Appendiceal Neoplasms; Disease-Free Survival; | 2012 |
Third look surgery and beyond for appendiceal malignancy with peritoneal dissemination.
Topics: Adenocarcinoma, Mucinous; Adult; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplas | 2003 |
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics.
Topics: Adenocarcinoma, Mucinous; Antibiotics, Antineoplastic; Antineoplastic Agents; Area Under Curve; Biol | 2003 |
Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy for the surgical palliation of mucinous peritoneal carcinomatosis from non-gynecologic cancer.
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasm | 2003 |
Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C.
Topics: Adenocarcinoma, Mucinous; Antibiotics, Antineoplastic; Area Under Curve; Ascitic Fluid; Body Surface | 2006 |
Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Combined | 2006 |
Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal N | 2006 |
[Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
Topics: Adenocarcinoma, Mucinous; Animals; Antibiotics, Antineoplastic; Charcoal; Drug Carriers; Drug Delive | 2006 |
Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
Topics: Adenocarcinoma, Mucinous; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Appen | 2007 |
Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antibiotics, Antineoplastic; Appendiceal Neoplasms; Biomarker | 2008 |
[Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Antibiotics, Antineoplastic; Antim | 2007 |
Changes in polymorphonuclear leukocyte motility under agarose and luminol-dependent chemiluminescence response in patients with gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Chemotaxis, Leukoc | 1984 |
Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
Topics: Adenocarcinoma, Mucinous; Aged; Colonic Neoplasms; Fluorouracil; Hemolytic-Uremic Syndrome; Humans; | 1983 |
Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; | 2001 |
Cutaneous metastases from gastric adenocarcinoma treated with combination chemotherapy producing complete response with long survival.
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ri | 2001 |
Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients.
Topics: Adenocarcinoma, Mucinous; Appendiceal Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; | 2001 |
Evaluation of intraoperative intraperitoneal cytology for advanced gastric carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Car | 2002 |
[A case of metastatic urinary bladder tumor from gastric carcinoma].
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fluorouracil; | 1992 |
[Clinical evaluation of intra-arterial infusion of hyperthermo-chemotherapy in gastric cancer].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 1991 |
Doxorubicin and cyclophosphamide, alternated with bleomycin and mitomycin C as a second-line regimen in advanced ovarian carcinoma resistant to cisplatin-based chemotherapy.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 1990 |
[Chemosensitivity of MGc 80-3 human gastric adenocarcinoma cells and its clinical significance].
Topics: Adenocarcinoma, Mucinous; Amdinocillin; Antineoplastic Agents; Drug Screening Assays, Antitumor; Flu | 1989 |
Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment.
Topics: Adenocarcinoma, Mucinous; Adult; Colonic Neoplasms; Combined Modality Therapy; Drug Therapy, Combina | 1987 |
Biological features and chemosensitivity of human colorectal cancer xenografted in nude mice.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Animals; Antineoplastic Agents; Carcinoembryonic Antigen; | 1987 |
[A gastric cancer showing marked improvement (stage IV) with lentinan immunotherapy and 5-FU, MMC-chemotherapy].
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Gastroscopy; | 1988 |
Radiation therapy for advanced gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; | 1988 |
[Experimental chemotherapy of human gastric cancer cell lines in vitro and in nude mice].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Allyl Compounds; Animals; Antibiotics, Antineoplastic; Cel | 1988 |
[A case of bilateral metastatic breast carcinoma from gastric carcinoma].
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined | 1986 |
Pharmacokinetics of mitomycin-C in plasma and tumor tissue of cervical cancer patients and in selected tissues of female rats.
Topics: Adenocarcinoma, Mucinous; Aged; Animals; Carcinoma, Squamous Cell; Female; Half-Life; Humans; Kineti | 1986 |
[Growth rate of human colorectal cancer xenografted in nude mice].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Animals; Carcinoembryonic Antigen; Cell Division; Cell Lin | 1987 |
Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma.
Topics: Aclarubicin; Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Age | 1987 |